tiprankstipranks
Trending News
More News >
Sundrug Co Ltd (JP:9989)
:9989
Japanese Market

Sundrug Co (9989) Ratios

Compare
1 Followers

Sundrug Co Ratios

JP:9989's free cash flow for Q4 2025 was ¥0.23. For the 2025 fiscal year, JP:9989's free cash flow was decreased by ¥ and operating cash flow was ¥0.05. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
1.69 1.34 1.82 2.08
Quick Ratio
0.92 0.75 1.09 1.32
Cash Ratio
0.51 0.45 0.71 0.93
Solvency Ratio
0.27 0.27 0.30 0.32
Operating Cash Flow Ratio
0.32 0.26 0.33 0.33
Short-Term Operating Cash Flow Coverage
8.48 1.18 439.76 660.04
Net Current Asset Value
¥ ―¥ 41.41B¥ 41.13B¥ 81.56B¥ 94.36B
Leverage Ratios
Debt-to-Assets Ratio
0.09 0.08 <0.01 <0.01
Debt-to-Equity Ratio
0.15 0.14 <0.01 <0.01
Debt-to-Capital Ratio
0.13 0.12 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.11 0.00 0.00 0.00
Financial Leverage Ratio
1.65 1.66 1.53 1.48
Debt Service Coverage Ratio
9.78 1.27 312.45 597.75
Interest Coverage Ratio
271.32 1.28K 1.04K 3.78K
Debt to Market Cap
0.08 0.06 <0.01 <0.01
Interest Debt Per Share
338.90 299.57 8.34 4.60
Net Debt to EBITDA
-0.41 -0.61 -1.60 -1.98
Profitability Margins
Gross Profit Margin
23.30%25.18%24.90%24.12%
EBIT Margin
5.55%5.49%5.47%5.35%
EBITDA Margin
7.72%7.52%7.21%6.92%
Operating Profit Margin
5.55%5.45%5.42%5.25%
Pretax Profit Margin
5.43%5.49%5.46%5.35%
Net Profit Margin
3.84%3.87%3.72%3.68%
Continuous Operations Profit Margin
3.84%3.87%3.72%3.68%
Net Income Per EBT
70.58%70.59%68.16%68.79%
EBT Per EBIT
97.91%100.64%100.69%101.83%
Return on Assets (ROA)
6.91%6.93%7.13%7.32%
Return on Equity (ROE)
11.40%11.51%10.88%10.81%
Return on Capital Employed (ROCE)
14.06%15.49%15.14%14.82%
Return on Invested Capital (ROIC)
9.77%9.66%10.31%10.20%
Return on Tangible Assets
7.05%7.09%7.31%7.46%
Earnings Yield
6.25%5.35%6.05%6.86%
Efficiency Ratios
Receivables Turnover
16.57 17.63 18.41 19.39
Payables Turnover
7.71 7.27 6.70 6.65
Inventory Turnover
6.23 6.16 6.25 6.79
Fixed Asset Turnover
5.87 6.24 5.43 8.33
Asset Turnover
1.80 1.79 1.91 1.99
Working Capital Turnover Ratio
11.37 10.34 7.04 6.40
Cash Conversion Cycle
33.27 29.74 23.81 17.74
Days of Sales Outstanding
22.03 20.70 19.83 18.83
Days of Inventory Outstanding
58.56 59.24 58.45 53.79
Days of Payables Outstanding
47.32 50.21 54.46 54.88
Operating Cycle
80.59 79.95 78.27 72.62
Cash Flow Ratios
Operating Cash Flow Per Share
351.94 352.21 319.70 270.98
Free Cash Flow Per Share
65.94 25.34 96.36 101.72
CapEx Per Share
286.00 326.87 223.33 169.26
Free Cash Flow to Operating Cash Flow
0.19 0.07 0.30 0.38
Dividend Paid and CapEx Coverage Ratio
0.86 0.81 1.03 1.13
Capital Expenditure Coverage Ratio
1.23 1.08 1.43 1.60
Operating Cash Flow Coverage Ratio
1.04 1.18 39.81 59.89
Operating Cash Flow to Sales Ratio
0.05 0.05 0.05 0.05
Free Cash Flow Yield
1.57%0.54%2.65%3.42%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
16.01 18.69 16.54 14.58
Price-to-Sales (P/S) Ratio
0.61 0.72 0.62 0.54
Price-to-Book (P/B) Ratio
1.83 2.15 1.80 1.58
Price-to-Free Cash Flow (P/FCF) Ratio
63.83 183.72 37.72 29.25
Price-to-Operating Cash Flow Ratio
11.96 13.22 11.37 10.98
Price-to-Earnings Growth (PEG) Ratio
2.88 1.41 2.13 -2.50
Price-to-Fair Value
1.83 2.15 1.80 1.58
Enterprise Value Multiple
7.54 9.02 6.93 5.77
Enterprise Value
466.81B 509.67B 345.08B 259.03B
EV to EBITDA
7.54 9.02 6.93 5.77
EV to Sales
0.58 0.68 0.50 0.40
EV to Free Cash Flow
60.52 172.01 30.63 21.78
EV to Operating Cash Flow
11.34 12.37 9.23 8.18
Tangible Book Value Per Share
2.23K 2.09K 1.94K 1.84K
Shareholders’ Equity Per Share
2.31K 2.16K 2.02K 1.89K
Tax and Other Ratios
Effective Tax Rate
0.29 0.29 0.32 0.31
Revenue Per Share
6.86K 6.43K 5.91K 5.55K
Net Income Per Share
262.90 249.06 219.83 204.02
Tax Burden
0.71 0.71 0.68 0.69
Interest Burden
0.98 1.00 1.00 1.00
Research & Development to Revenue
0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00
Income Quality
1.34 1.41 0.99 0.91
Currency in JPY